Hormonal Contraceptives Market by Hormone (Androgens, Antiandrogens, Estrogens), Method (Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives), End-user - Global Forecast 2024-2030

Hormonal Contraceptives Market by Hormone (Androgens, Antiandrogens, Estrogens), Method (Combined Oral Contraceptives, Implanted Contraceptives, Injected Contraceptives), End-user - Global Forecast 2024-2030


The Hormonal Contraceptives Market size was estimated at USD 17.19 billion in 2023 and expected to reach USD 18.34 billion in 2024, at a CAGR 6.76% to reach USD 27.19 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hormonal Contraceptives Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hormonal Contraceptives Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hormonal Contraceptives Market, highlighting leading vendors and their innovative profiles. These include Afaxys Pharma, LLC, Agile Therapeutics, Amgen Inc., Bayer AG, Boehringer Ingelheim GmbH, Cipla Limited, Glenmark Pharmaceuticals Limited, HLL Lifecare Limited, Johnson & Johnson Services, Inc., Lupin Pharmaceuticals, Inc., Novartis AG, Pfizer, Inc., Piramal Group, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage



This research report categorizes the Hormonal Contraceptives Market to forecast the revenues and analyze trends in each of the following sub-markets:

Hormone
Androgens
Antiandrogens
Estrogens
Gonadotropins
Progestogens
Method
Combined Oral Contraceptives
Implanted Contraceptives
Injected Contraceptives
Intrauterine
Oral Contraceptives
Transdermal Patch
Vaginal Ring
End-user
Ambulatory Surgical Centers
Gynecology Centers
Homecare
Hospitals & Clinics
Region
Americas
Argentina

Brazil

Canada

Mexico

United States
California

Florida

Illinois

New York

Ohio

Pennsylvania

Texas
Asia-Pacific
Australia

China

India

Indonesia

Japan

Malaysia

Philippines

Singapore

South Korea

Taiwan

Thailand

Vietnam
Europe, Middle East & Africa
Denmark

Egypt

Finland

France

Germany

Israel

Italy

Netherlands

Nigeria

Norway

Poland

Qatar

Russia

Saudi Arabia

South Africa

Spain

Sweden

Switzerland

Turkey

United Arab Emirates

United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Hormonal Contraceptives Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hormonal Contraceptives Market?
3. What are the technology trends and regulatory frameworks in the Hormonal Contraceptives Market?
4. What is the market share of the leading vendors in the Hormonal Contraceptives Market?
5. Which modes and strategic moves are suitable for entering the Hormonal Contraceptives Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Hormonal Contraceptives Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of pregnancy-related health risks in women
5.1.1.2. Government initiatives to promote the use of contraceptives
5.1.1.3. Availability of oral contraceptives online
5.1.2. Restraints
5.1.2.1. Side effects of hormonal contraceptives
5.1.3. Opportunities
5.1.3.1. Research studies for producing highly effective contraceptive methods
5.1.3.2. Improving advertisements and marketing of hormonal contraceptives
5.1.4. Challenges
5.1.4.1. Limited social acceptance of hormonal contraceptives
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Hormonal Contraceptives Market, by Hormone
6.1. Introduction
6.2. Androgens
6.3. Antiandrogens
6.4. Estrogens
6.5. Gonadotropins
6.6. Progestogens
7. Hormonal Contraceptives Market, by Method
7.1. Introduction
7.2. Combined Oral Contraceptives
7.3. Implanted Contraceptives
7.4. Injected Contraceptives
7.5. Intrauterine
7.6. Oral Contraceptives
7.7. Transdermal Patch
7.8. Vaginal Ring
8. Hormonal Contraceptives Market, by End-user
8.1. Introduction
8.2. Ambulatory Surgical Centers
8.3. Gynecology Centers
8.4. Homecare
8.5. Hospitals & Clinics
9. Americas Hormonal Contraceptives Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hormonal Contraceptives Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Hormonal Contraceptives Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Afaxys Pharma, LLC
13.1.2. Agile Therapeutics
13.1.3. Amgen Inc.
13.1.4. Bayer AG
13.1.5. Boehringer Ingelheim GmbH
13.1.6. Cipla Limited
13.1.7. Glenmark Pharmaceuticals Limited
13.1.8. HLL Lifecare Limited
13.1.9. Johnson & Johnson Services, Inc.
13.1.10. Lupin Pharmaceuticals, Inc.
13.1.11. Novartis AG
13.1.12. Pfizer, Inc.
13.1.13. Piramal Group
13.1.14. Sun Pharmaceutical Industries Ltd.
13.1.15. Teva Pharmaceutical Industries Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. HORMONAL CONTRACEPTIVES MARKET RESEARCH PROCESS
FIGURE 2. HORMONAL CONTRACEPTIVES MARKET SIZE, 2023 VS 2030
FIGURE 3. HORMONAL CONTRACEPTIVES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HORMONAL CONTRACEPTIVES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HORMONAL CONTRACEPTIVES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HORMONAL CONTRACEPTIVES MARKET DYNAMICS
FIGURE 7. HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2023 VS 2030 (%)
FIGURE 8. HORMONAL CONTRACEPTIVES MARKET SIZE, BY HORMONE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 10. HORMONAL CONTRACEPTIVES MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. HORMONAL CONTRACEPTIVES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HORMONAL CONTRACEPTIVES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HORMONAL CONTRACEPTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HORMONAL CONTRACEPTIVES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. HORMONAL CONTRACEPTIVES MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings